RiBBON 1 and RiBBON 2: phase III trials of bevacizumab with standard chemotherapy for metastatic breast cancer.
O'Shaughnessy
Joyce A
JA
Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center, Texas Oncology, P.A., US Oncology, Dallas, TX, USA. joyce.oshaughnessy@usoncology.com
Brufsky
Adam M
AM